LFG
XENE icon

Larson Financial Group’s Xenon Pharmaceuticals XENE Stock Holding History

Larson Financial Group’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.02K Buy
52
+50
+2,500% +$2.3K ﹤0.01% 2827
2025
Q4 		$90 Hold
2
– – ﹤0.01% 3346
2025
Q3 		$80 Buy
+2
New +$70 ﹤0.01% 3336
2023
Q4 		– Sell
-17
Closed -$581 – 1912
2023
Q3 		$581 Buy
+17
New +$636 ﹤0.01% 1559

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Larson Financial Group's XENE Position: Q1 2026 in Review

Larson Financial Group increased its Xenon Pharmaceuticals (XENE) stake by 2,500% in Q1 2026, buying an estimated $2.3K and bringing the position to 52 shares worth $3.02K. The position accounts for ﹤0.01% of the portfolio, ranked #2827.

Larson Financial Group first reported a position in XENE in Q3 2023 and has held it in 4 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

  • Larson Financial Group held 52 shares of Xenon Pharmaceuticals worth $3.02K as of Q1 2026.
  • Larson Financial Group bought 50 Xenon Pharmaceuticals shares in Q1 2026, an estimated $2.3K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2827 holding.
  • Larson Financial Group first reported a position in Xenon Pharmaceuticals in Q3 2023 and has held it in 4 quarters since.
  • 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.